© Globe Newswire
19.04.2025
ZEAL
LISTED
CPH
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025
News Preview
Company announcement – No. 9 / 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
18.04.2025
IBAB
LISTED
EURONEXT
IBA – ACQUISITION OF OWN SHARES
News Preview
Immediate Release – April 18th, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
18.04.2025
TEM
LISTED
NASDAQ
Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S.
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the launch of the Tempus Advisory Board. The Tempus Advisory Board is a vital resource for the company in maintaining high standards and ensuring that the strategy and offerings continue to be grounded in e...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
18.04.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025
News Preview
CONSHOHOCKEN, Pa., April 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), announced today that it will release its first-quarter 2025 financial results on Thursday, May 1, 2025, prior to the...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
17.04.2025
EHAB
LISTED
NYSE
Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call
News Preview
Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the sch...
Themefolio
Profiler
Peergroup
© PR Newswire
17.04.2025
HIK
LISTED
LSE
Hikma acquires Novugen's FDA-approved ANDA for trametinib
News Preview
LONDON, April 17, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug Application (ANDA) for trametinib tablets from Novugen. Hikma also announces it has entered into a commercial agreement with Novugen where Hikma will be responsib...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2025
SOON
LISTED
SIX
Sonova schliesst Aktienrückkauf 2022-25 ab
News Preview
Sonova Holding AG
/ Schlagwort(e): Aktienrückkauf
Sonova schliesst Aktienrückkauf 2022-25 ab
17.04.2025 / 18:00 CET/CEST
Investor Release
Stäfa (Schweiz), 17. April 2025 – Sonova Holding AG (SWX: SOON), ein führender Anbieter innovativer Hörlösungen, gibt heute den Abschluss des Aktienrückkaufprogramms bekannt, welches ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2025
SOON
LISTED
SIX
Sonova concludes 2022-25 share buyback
News Preview
Sonova Holding AG
/ Key word(s): Share Buyback
Sonova concludes 2022-25 share buyback
17.04.2025 / 18:00 CET/CEST
Investor Release
Stäfa (Switzerland), April 17, 2025 – Sonova Holding AG (SWX: SOON), a leading provider of hearing care solutions, today announces the conclusion of its 2022-25 share buyback program, which ......
Themefolio
Profiler
Peergroup
© PR Newswire
17.04.2025
CU6
LISTED
ASX
Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano
News Preview
Highlights
Clarity has signed a commercial-scale agreement with Nusano, Inc. ("Nusano") for supply of copper-64 (Cu-64 or 64Cu) isotope.The 190,000 square foot Nusano facility in West Valley City, Utah is capable of producing more than 1,000 Ci (37,000 GBq) of copper-64 per day at capacity, which translates into more than 18,000 patient doses per...
Themefolio
Profiler
Peergroup
© PR Newswire
17.04.2025
AFX
LISTED
XETR
ZEISS continues to drive digital era forward in ophthalmology; celebrates 2 million digitally-planned cataract cases in the U.S. alone
News Preview
Showcasing at ASCRS 2025:
More than 2 million cases planned with ZEISS VERACITY Surgery Planner: Growing use of one of the leading digital planning solutions for cataract surgery in the U.S. is a testament to the increased adoption of the ZEISS Cataract Workflow digital solutions by surgeons.ZEISS MEL 90 broadens refractive treatment portfolio: U...
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2025
EVT
LISTED
XETR
Evotec SE stellt neue Strategie vor und gibt Ausblick für 2025 gestützt durch starkes Ergebnis im 4. Quartal 2024
News Preview
Evotec fokussiert sich auf wegweisende Wirkstoffforschung und zeigt Weg zu nachhaltigem, profitablem Wachstum auf
Strategie baut auf Vorreiterrolle in Technologie- und Wissenschaft auf, konzentriert sich auf wachstumsstarke, hochwertige Segmente, vereinfacht das Geschäftsmodell und fördert operative Exzellenz
Starke Umsatz- und E......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2025
EVT
LISTED
XETR
Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results
News Preview
Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth
Strategy builds on technology and science leadership, focusing on high-growth, high-value segments, simplifying the business model and fostering operational excellence
Strong Q4 2024 revenue and EBITDA results in spite of ch......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESSWIRE
17.04.2025
EVT
LISTED
XETR
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results
News Preview
Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growthStrategy builds on technology and science leadership, focusing on high-growth, high-value segments, simplifying the business model and fostering operational excellenceStrong Q4 2024 revenue and EBITDA results in spite of challenging market c...
Themefolio
Profiler
Peergroup
© PR Newswire
16.04.2025
RXRX
LISTED
NASDAQ
HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data
News Preview
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, has licensed its real-world data to enhance clinical trial design and an...
Themefolio
Profiler
Peergroup
© BusinessWire
16.04.2025
BLUE
LISTED
NASDAQ
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
News Preview
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird” or “the Company”) today announced that after three weeks of engagement, including a timeline extension, Ayrmid Ltd. (“Ayrmid”) has not submitted a binding proposal to acquire bluebird and has not obtained necessary financing. In consultation with its financial and legal advisors, the bluebird Board of...
Themefolio
Profiler
Peergroup
© BusinessWire
16.04.2025
OGI
LISTED
NASDAQ
New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada’s economy through homegrown industries, including the legal cannabis sector.
This press release features multimedia. View the full...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.04.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
News Preview
Dr. Taub’s pioneering research in academia and industry led to the first FDA-approved therapy for patients with MASH Dr. Taub’s pioneering research in academia and industry led to the first FDA-approved therapy for patients with MASH...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.04.2025
REC
LISTED
EURONEXT
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
News Preview
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.04.2025
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): Quarter Results/Forecast
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025 16-Apr-2025 / 07:00 CET/CEST
Aubagne, France | April 16, 2025
Sartorius Stedim Biotech publishes unaudited first quarter results for 2025
Sales revenue at 745 million euros, up 10.4......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.04.2025
SRT3
LISTED
XETR
Sartorius erreicht im ersten Quartal deutlich profitables Wachstum
News Preview
Göttingen, 16. April 2025
Starker Jahresauftakt: Sartorius erreicht im ersten Quartal deutlich profitables Wachstum
Konzernumsatz legt um 6,5 Prozent zu
Hohe Nachfrage nach Verbrauchsmaterialien: Umsatz der Sparte Bioprocess Solutions wächst um fast 10 Prozent; demgegenüber Laborsparte erwartungsgemäß mit gedämpfter Entwicklung
Sehr gute Entwi......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.04.2025
SRT3
LISTED
XETR
Sartorius achieves significant profitable growth in the first quarter
News Preview
Göttingen, Germany | April 16, 2025
Strong start to the year: Sartorius achieves significant profitable growth in the first quarter
Group sales revenue up 6.5 percent
High demand for consumables: sales revenue in the Bioprocess Solutions division up by almost 10 percent; in contrast, development in lab division muted, as expected
Very good dev......
Themefolio
Profiler
Peergroup
© PR Newswire
15.04.2025
CU6
LISTED
ASX
SECuRE trial update: First patient treated in the Phase II Cohort Expansion
News Preview
HIGHLIGHTS
The first of the planned 24 participants in the Cohort Expansion Phase (Phase II) of the SECuRE trial has been treated with their first dose of 8 GBq of 67Cu-SAR-bisPSMA.This follows the recent recommendation by the Safety Review Committee (SRC) after the successful completion of the Dose Escalation Phase to commence enrollment for the...
Themefolio
Profiler
Peergroup
© BusinessWire
15.04.2025
DFTX
LISTED
NASDAQ
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has been dosed in its Phase 3 Emerge study evaluating MM120 ODT, a proprietary, pharmaceutically optimized form of LSD...
Themefolio
Profiler
Peergroup
© PR Newswire
15.04.2025
SOBI
LISTED
STO
Invitation: Sobi's Q1 report
News Preview
STOCKHOLM, April 15, 2025 /PRNewswire/ -- Sobi plans to publish its report for the first quarter of 2025 on 29 April 2025 at 08:00 CET.
Investors, analysts, and the media are invited to a conference call on the same day at 15:30 CET, 14:30 GMT, and 09:30 EST. The call will include a presentation of the results and a Q&A session.
The presenta...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.04.2025
COLO B
LISTED
CPH
Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST
News Preview
Tuesday, 6 May 2025 at 11.00 - 12.00am CESTIn connection with the publication of Coloplast’s interim financial results for H1 2024/25, to be released same day around 07.30am CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Col...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.04.2025
GMAB
LISTED
CPH
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
15.04.2025
AFX
LISTED
XETR
Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
News Preview
Carl Zeiss Meditec achieves significant earnings increase in Q2 2024/25
Jena, April 15, 2025
In the second quarter of fiscal year 2024/25 ending March 31, 2025, Carl Zeiss Meditec AG (ISIN: DE0005313704) has achieved revenue of around EUR 560 million (previous year: EUR 472.1 million), based on preliminary data, an increase of around 19%.......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.04.2025
AFX
LISTED
XETR
Carl Zeiss Meditec erzielt deutliche Gewinnsteigerung im zweiten Quartal 2024/25
News Preview
Carl Zeiss Meditec erzielt deutliche Gewinnsteigerung im zweiten Quartal 2024/25
Jena, 15. April 2025
Im zweiten Quartal des Geschäftsjahres 2024/25 zum 31. März 2025 erzielte die Carl Zeiss Meditec AG (ISIN: DE0005313704) auf Basis vorläufiger Daten einen Umsatz von rund 560 Millionen (Mio.) EUR (Vorjahr 472,1 Mio. EUR) – ein Anstieg von......
Themefolio
Profiler
Peergroup
© PR Newswire
15.04.2025
SECT_B
LISTED
STO
Leading Australian private hospital chooses Sectra's enterprise imaging solution for efficient workflows and better patient outcomes
News Preview
LINKÖPING, Sweden, April 15, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will deliver its enterprise imaging solution to Sydney Adventist Hospital (SAH) in Australia. The solution will allow their clinicians to complete the entire diagnostic process within a single application, with all nec...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.04.2025
ORNBV
LISTED
HEL
Statutory negotiations at Orion's R&D unit in Turku, Finland have been concluded
News Preview
ORION CORPORATION PRESS RELEASE 15 April 2025 at 10.00 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.04.2025
IBAB
LISTED
EURONEXT
IBA – ACQUISITION OF OWN SHARES
News Preview
Immediate Release – April 14th, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
14.04.2025
ATNM
LISTED
XASE
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
News Preview
Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity Insider News Commentary – Routine medical appointments or cancer screenings—critical for catching the disease in earlier, more treatable stages—has dropped to just over 50% of the population. At the same time, doctors ar...
Themefolio
Profiler
Peergroup
© PR Newswire
14.04.2025
ATNM
LISTED
XASE
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
News Preview
Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity Insider News Commentary – Routine medical appointments or cancer screenings—critical for catching the disease in earlier, more treatable stages—has dropped to just over 50% of the population. At the same time, doctors ar...
Themefolio
Profiler
Peergroup
© PR Newswire
14.04.2025
ATNM
LISTED
XASE
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
News Preview
Equity Insider News Commentary
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, April 14, 2025 /CNW/ -- Equity Insider News Commentary – Routine medical appointments or cancer screenings—critical for catching the disease in earlier, more treatable stages—has dropped to just over 50% of the population. At the same time, doctors are raisi...
Themefolio
Profiler
Peergroup
© BusinessWire
14.04.2025
ZLAB
LISTED
NASDAQ
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025
News Preview
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its first quarter 2025 financial results and provide recent corporate updates on May 8, 2025, before the opening of the U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT).
Conference Call and Webcast...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.04.2025
SKYE
LISTED
NASDAQ
Skye Bioscience to Conduct Meetings at Piper Sandler Conference
News Preview
SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that its executive team will be available for 1x1 meetings at the Piper Sandler Spring Biopharma Sym...
Themefolio
Profiler
Peergroup
© PR Newswire
14.04.2025
RAY B
LISTED
STO
Invitation to Annual General Meeting 2025
News Preview
STOCKHOLM, April 14, 2025 /PRNewswire/ -- The shareholders in RaySearch Laboratories AB (publ), corporate identity no. 556322-6157, are hereby invited to the Annual General Meeting, to be held on Thursday, May 22, 2025, at 6.00 p.m. at the company's office at Eugeniavägen 18C, Stockholm, Sweden. Registration will start at 5.00 p.m. and light refr...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.04.2025
NSIS B
LISTED
CPH
Transactions under Novonesis’ share buyback program
News Preview
Please read the announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.04.2025
DBV
LISTED
EURONEXT
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
News Preview
Châtillon, France, April 11, 2025...
Themefolio
Profiler
Peergroup
© ActuNews
11.04.2025
OXUR
LISTED
EURONEXT
OXURION : Publication Annual Report - Annual Shareholders' Meeting
News Preview
Leuven, BELGIUM – April 11, 2025 – 08:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial year 2024. The annual report for the year ending December 31, 2024 is available in the “Investors” section of the Company's w...
Themefolio
Profiler
Peergroup
© ActuNews
11.04.2025
OXUR
LISTED
EURONEXT
OXURION : Publicatie jaarverslag - Jaarlijkse Algemene Vergadering
News Preview
Leuven, BELGIË – 11 april 2025 – 20u00 CET Oxurion NV (Euronext Brussel: OXUR), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, België, heeft vandaag zijn jaarverslag over boekjaar 2024 gepubliceerd. Het jaarverslag voor het boekjaar afgesloten per 31 december 2024 is beschikbaar in de sectie “ Investeerders&rdq...
Themefolio
Profiler
Peergroup
© BusinessWire
11.04.2025
AMRX
LISTED
NASDAQ
Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced donations totaling $1.5 million to multiple patient assistance foundations that support individuals living with Parkinson’s disease in honor of Parkinson’s Awareness Month. These contributions underscore Amneal's ongoing com...
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2025
EUZ
LISTED
XETR
Eckert & Ziegler Proposes Dividend of € 0.50 for FY 2024
News Preview
Berlin, 11 April 2025. The Supervisory Board of Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) approved the Executive Board's resolution to propose a dividend of € 0.50 per share entitled to a dividend for the 2024 financial year at the Annual General Meeting to be held on June 18, 2025 in Berlin. The 2024 annual financial statements of Eckert......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2025
EUZ
LISTED
XETR
Eckert & Ziegler schlägt Dividende von 0,50 € für das GJ 2024 vor
News Preview
Berlin, 11. April 2025. Der Aufsichtsrat der Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) hat dem Vorschlag des Vorstands zugestimmt, der in Präsenz stattfindenden Hauptversammlung am 18. Juni 2025 eine Dividende in Höhe von 0,50 € pro dividendenberechtigte Aktie für das Geschäftsjahr 2024 vorzuschlagen. In der Bilanzsitzung vom 10.4.2025 wu......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2025
GXI
LISTED
XETR
Umsatz- und Ergebnis-Sprung durch Bormioli Pharma
News Preview
Gerresheimer: Umsatz- und Ergebnis-Sprung durch Bormioli Pharma
Umsatz +11,6 %, Adjusted EBITDA +13,1 %
Organische Entwicklung gegenüber Pro-forma-Zahlen Q1 2024: Umsatz -6,5 %, Adjusted EBITDA -9,3 %
Q1 wesentlich beeinflusst von Umsatzverschiebung im Spritzengeschäft
Prognose 2025 bestätigt: organisches Umsatzwachstum von 3-5 % und Adjusted ......
Themefolio
Profiler
Peergroup
© EQS Newswire
11.04.2025
GXI
LISTED
XETR
Bormioli Pharma boosts revenues and earnings
News Preview
Gerresheimer: Bormioli Pharma boosts revenues and earnings
Revenues +11.6%, Adjusted EBITDA +13.1%
Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3%
Q1 significantly influenced by revenue shift in syringe business
Guidance 2025 confirmed: organic revenue growth of 3-5% and adjusted EBITDA margin of......
Themefolio
Profiler
Peergroup
© Globe Newswire
11.04.2025
FAGR
LISTED
EURONEXT
Fagron publishes agenda for 2025 annual shareholders meeting
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
1SXP
LISTED
XETR
SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
News Preview
SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
Based on preliminary figures, SCHOTT Pharma expects an increase in sales, EBITDA and EBITDA margin in the second quarter of 2025 (as of March 31, 2025). The company expects Q2 2025 revenues of EUR 252m, corresponding to a year-over-year growth of 10% at constant currenc......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
1SXP
LISTED
XETR
SCHOTT Pharma: Vorläufiges Q2 2025-Ergebnis liegt über den Markterwartungen
News Preview
SCHOTT Pharma: Vorläufiges Q2 2025-Ergebnis liegt über den Markterwartungen
SCHOTT Pharma erwartet auf Basis vorläufiger Zahlen einen Anstieg bei Umsatz, EBITDA und EBITDA-Marge für das zweite Quartal 2025 (zum 31. März 2025). Das Unternehmen rechnet mit einem Umsatz in Höhe von 252 Mio. Euro und einem währungsbereinigten Wachstum von 10 %. Dami......
Themefolio
Profiler
Peergroup
© Globe Newswire
10.04.2025
GMAB
LISTED
CPH
Genmab A/S Share Capital Reduction
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
1SXP
LISTED
XETR
SCHOTT Pharma eröffnet Produktionsstätte in Serbien zur Stärkung der Wettbewerbsfähigkeit in Europa
News Preview
Nächster Expansionsmeilenstein erreicht: SCHOTT Pharma eröffnet Produktionsstätte in Serbien zur Stärkung der Wettbewerbsfähigkeit in Europa
April 10, 2025, Jagodina, Serbia
Nach einer Investition im zweistelligen Millionenbereich und einer Bauzeit von weniger als eineinhalb Jahren eröffnet SCHOTT Pharma eine neue Produktionsstätte in Jagodina, S......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
1SXP
LISTED
XETR
SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
News Preview
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
April 10, 2025, Jagodina, Serbia
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia
Production capacity to meet European mar......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
EUZ
LISTED
XETR
US Consul Visits Radiopharmaceutical Production in Braunschweig
News Preview
Berlin, 10 April 2025. US Consul General Jason Chue today visited the Eckert & Ziegler production site in Braunschweig and gained an impression of the production of radiopharmaceuticals for cancer diagnostics and therapy. Eckert & Ziegler maintains a long-standing relationship with the USA. The isotope specialist generates almost 40% of its......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
EUZ
LISTED
XETR
US-Generalkonsul besucht Radiopharmazeutikaherstellung in Braunschweig
News Preview
Berlin, 10. April 2025. US-Generalkonsul Jason Chue besuchte heute den Eckert & Ziegler Produktionsstandort in Braunschweig und verschaffte sich einen Eindruck über die Herstellung von Radiopharmazeutika für Krebsdiagnostik und -therapie. Mit den USA verbindet Eckert & Ziegler seit langem ein festes Band. Der Isotopenspezialist erzielt knap......
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
VITR
LISTED
STO
The Vitrolife Group appoints Pär Ihrskog as the new Chief Financial Officer
News Preview
GOTHENBURG, Sweden, April 10, 2025 /PRNewswire/ -- Pär Ihrskog has been appointed CFO of the Vitrolife Group effective 10 October 2025. Pär currently serves as CFO at Bufab Group and brings a wealth of experience to the company, having also served as Group CFO/CIO at Embellence Group. He spent the majority of his career working in finance roles,...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
EVT
LISTED
XETR
Evotec SE to announce results for financial year 2024 on 17 April 2025
News Preview
Hamburg, Germany, 10 April 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 April 2025.
The Company is going to host a conference call to discuss 2024 results as well as to provide an update on the concluded strategic review process. The confe......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.04.2025
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das Geschäftsjahr 2024 am 17. April 2025
News Preview
Hamburg, 10. April 2025:
Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Donnerstag, 17. April 2025, ihren Bericht für das Geschäftsjahr 2024.
In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse des Geschäftsjahres 2024 präsentiert und erläutert. Außerdem wird ein ......
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
VITR
LISTED
STO
Conference call interim report
News Preview
GOTHENBURG, Sweden, April 10, 2025 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1 2025. The presentation will be held in English.
Time: Thursday 24 April, 2025 at 10.00 a.m. CET.
To attend the conference call, please use this link to register. After registration, you will...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.04.2025
ORNBV
LISTED
HEL
The Helsinki Court of Appeal sentenced a member of Orion's Board of Directors to a fine for a securities market information offence
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE10 APRIL 2025 at 13.15 EEST ...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
ORX
LISTED
STO
Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology
News Preview
The study was conducted in partnership with Abera Bioscience, a platform and vaccine developer with over 30 years of research in the medical, molecular and microbiological fields.Both formulations tested induced strong systemic antibody response in serum (IgG) as well as locally in the nose and lungs (IgA).The collaboration is in line with Orexo'...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
